The most commonly reported adverse events of cefoperazone were a decreased prothrombin level (7.94%), hemorrhage (6.74%), pyrexia (6.63%), dermatitis (5.71%), thrombocytopenia (5.44%), and shock (5.22%). This evidence concerns the gene F2 and dermatitis.